GENE
Genetic Technologies
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About GENE
Genetic Technologies Limited
A global leader in genomics-based tests in health, wellness, and serious disease
Life Science Tools and Services
01/05/1987
09/02/2005
NASDAQ Stock Exchange
60
06-30
Depository Receipts (Ordinary Shares)
60-66 Hanover Street, Fitzroy, Victoria, 3065, Australia
Genetic risk test
Genetic Technologies Limited was incorporated under the laws of Western Australia on 5 January 1987 as Concord Mining N.L. The company is a molecular diagnostic company that provides predictive testing and assessment tools to help physicians proactively manage people's health. The company's traditional product, BREVAGenplus, is a clinically proven non-hereditary breast cancer risk assessment test, the first of its kind. BREVAGenplus improves the predictive power of the first-generation BREVAGen test, designed to facilitate more informed decisions about breast cancer screening and preventive treatment plans.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
